Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC24H23NO2 |
InChIKeyYNYOWRRXJIPCGX-UHFFFAOYSA-N |
CAS Registry1141802-49-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | NL | 09 Apr 2009 |